2nd Quarter - Report

VERTEX PHARMACEUTICALS INCORPORATED for VERTEX PHARMACEUTICALS INCORPORATED

Firm
Client
Income
—
Expenses
$170,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to raising awareness of Hepatitis C (no specific bills); H.R. 3293, H.R. 3288: FY 2010 Labor/HHS/Education Appropriations, provisions related to viral hepatitis funding; H.R. 3974: Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009, all provisions; FY 2011 Labor/HHS/Education Appropriations, provisions related to viral hepatitis funding.

LobbyistCovered position, as disclosed
JEREMY ALLEN —
EUSTACIA LEE REIDY —
AMIT K SACHDEV —

Contacted: HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA); Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); SENATE

Bills named: H.R. 3974 (111th), H.R. 3293 (111th), H.R. 3288 (111th)

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.